Previous Blogs

Avatar

By Global Communications

September 30, 2014

West Pharmaceutical Services Brazil is pleased to host the VII Technical Symposium on October 28, 2014, at the Melia Hotel Jardim Europa in Sao Paulo, Brazil. 

Avatar

By Global Communications

May 20, 2014

Diane Paskiet, Director, Scientific Affairs, serves as co-chair for the 2014 PDA Packaging Conference: Pharmaceutical Packaging Systems – Current and Emerging Practices, Technologies and Materials, which will be held at the Washington Marriott Wardman Park, Washington, D.C. on May 20-21, 2014.

Avatar

By Global Communications

April 21, 2014

West’s Mike Schaefers and Heike Kofler recently published a chapter entitled, “Primary Packaging Components Elastomeric Closures for Pharmaceutical Applications” to APV Basics Pharmazeutische Packmittel (Elastomeric Pharmaceutical Packaging).

Avatar

By Jessica Teigs

April 03, 2014

When selecting parenteral packaging components, the vial and stopper are typically discussed, but the seal is often an afterthought. Seals do not have direct product contact and are considered secondary packaging. However, the selection of an appropriate seal is critical to assure proper container closure integrity as well as determine how the product will function for the end user.

Avatar

By Joanne Neizer

March 24, 2014

The future is now for parenteral pharmaceutical and biopharmaceutical sterile production. Traditional high-volume automated aseptic filling suites are maintained by contract filling services. But what’s emerging? Parenteral pharmaceutical and biopharmaceutical industries have transitioned to fully enclosed, isolator/restricted access barrier (RAB) systems. These small, efficient systems offer cost savings and can reduce the potential for particulate and microbial ingress during aseptic fill/finish manufacturing by eliminating direct human contact in the filling environment.

Avatar

By Joanne Neizer

January 14, 2014

Natural Rubber Latex (NRL) has been a topic of concern in the pharmaceutical industry since the early 1990s. Concerns with allergens prompted labeling guidelines to ensure safe patient treatment. West Pharmaceutical Services’ elastomeric formulations for injectable packaging components for vials and syringes may contain Dry Natural Rubber (DNR) in the form of crepe, but the formulations do not incorporate NRL.